HIV Drug Might Defuse Deadly Staph Infections, NYU School of Medicine Study  
12/17/2012 7:40:18 AM

A new study by NYU School of Medicine researchers suggests that an existing HIV drug called maraviroc could be a potential therapy for Staphylococcus aureus, a notorious and deadly pathogen linked to hundreds of thousands of hospitalizations each year. Their study is published online this week in Nature.